Wave Life Sciences
189 hedge funds and large institutions have $1.05B invested in Wave Life Sciences in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 18 closing their positions.
101% more call options, than puts
Call options by funds: $9.64M | Put options by funds: $4.79M
78% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 18
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
16% more capital invested
Capital invested by funds: $903M → $1.05B (+$148M)
7% more funds holding
Funds holding: 176 → 189 (+13)
0.97% more ownership
Funds ownership: 89.31% → 90.29% (+0.97%)
2% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 62
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.5M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$30.3M |
| 3 |
SC
Stempoint Capital
New York
|
+$9.79M |
| 4 |
Goldman Sachs
New York
|
+$9.05M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.27M |
| 2 |
Morgan Stanley
New York
|
-$8.39M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$8.35M |
| 4 |
JP Morgan Chase
New York
|
-$5.74M |
| 5 |
Primecap Management
Pasadena,
California
|
-$4.59M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
201
Algert Global
San Francisco,
California
| – | -$172K | -26,420 | Closed |
|
202
Nomura Holdings
Tokyo,
Japan
| – | -$120K | -14,829 | Closed |
|
|
SO
203
STRS Ohio
Columbus,
Ohio
| – | -$52K | -8,000 | Closed |
|
|
RAM
204
Riggs Asset Management
Dallas,
Pennsylvania
| – | -$1.29K | -198 | Closed |
|
|
TPWA
205
Twin Peaks Wealth Advisors
Burlingame,
California
| – | -$34 | -4 | Closed |
|
WVE Hedge Fund Activity: Q3 2025 in Review
189 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2025, worth a combined $1.05B — up 16% from $903M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new WVE positions and 18 closed out — a net gain of 14 holders — while 61 added to existing stakes and 62 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $36.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $9.27M.
- 189 institutional investors held Wave Life Sciences (WVE) as of Q3 2025, up from 176 in Q2 2025.
- Funds reported $1.05B of Wave Life Sciences stock for Q3 2025, up 16% quarter-over-quarter.
- 32 funds opened new Wave Life Sciences positions in Q3 2025 and 18 closed out, a net change of +14 holders.
- The largest Wave Life Sciences buyer in Q3 2025 was Fidelity Investments, an estimated $36.5M added.
- The largest Wave Life Sciences seller in Q3 2025 was T. Rowe Price Associates, an estimated $9.27M sold.
Based on aggregated 13F filings for Q3 2025.